Crossmark

The potential toxic impact of different gadolinium-based contrast agents combined with 7-T MRI on isolated human lymphocytes

Crossref DOI link: https://doi.org/10.1186/s41747-018-0069-y

Published Online: 2018-11-28

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Friebe, Björn

Godenschweger, Frank

Fatahi, Mahsa

Speck, Oliver

Roggenbuck, Dirk

Reinhold, Dirk

Reddig, Annika http://orcid.org/0000-0001-6587-206X
License Information

Text and Data Mining valid from 2018-11-28
More Information

Article History

Received: 17 May 2018

Accepted: 9 October 2018

First Online: 28 November 2018

Ethics approval and consent to participate

: This <i>in vitro</i> study was approved by the local ethics committee and written informed consent was obtained from all participants.

: Not applicable.

: D. Roggenbuck is a shareholder of Medipan GmbH and has a patent PCT/EP2012/06499, US 8,835,122, AU11168799.2 issued. O.S. reports grants from European Commission during the course of the study and grants from Siemens Healthcare. This support, however, is not related to the subject of the current study. The remaining authors declare no conflict of interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.